Searchable abstracts of presentations at key conferences in endocrinology

ea0011p9 | Bone | ECE2006

Bone mineral density in patients with type 1 diabetes

Giorgadze Elen , Tsagareli Marina , Jikurauli Nino , Svani Nino

Background: Type1 diabetes is associated with reduction in Bone mineral density (BMD). It is thought, that metabolic abnormalities associated with type 1 diabetes alter the BMD, but the pathologic mechanisms of reduced bone mass are not fully understood.Objective: The aim of our study was to reveal whether the metabolic control affects bone mass in patients with type 1 diabetes.Materials and Methods: We studied 80 patients (45 -mal...

ea0020p513 | Endocrine Disruptors | ECE2009

Hyperprolactinaemia in men

Giorgadze Elen , Janjgava Shota , Lomidze Marina , Bakchtadze Tamta , Nozadze Natia , Uchava lasha , Svani Nino

The hyperprolactinemic disorder is a syndrome of prolactin hypersecretion. The syndrome is more prevalent in women than in men, but lately accidence of the syndrome disease tends to increase in men. Hyperprolactinemic disorder mostly affects men at the age range 40–59 years. Patients at the physician’s consultation have following complaints: erectile dysfunction, infertility, libido reduction, rarely gynecomastia.Sixteen patients were examined ...

ea0014p41 | (1) | ECE2007

Effectiveness of α-lipoic acid in prevention of peripheral diabetic neuropathy

Jikurauli Nino , Giorgadze Ellen , Svani Nino , Chachibaia Vasil , Bestavashvili Felix , Lominadze Tea , Chanturia Nia , Malazonia Anna

Background: The aim of our study was to assess the effectiveness of α-lipoic acid for the reducing the risk of developing peripheral diabetic neuropathy.Subjects and methods: We have studied 38 patients with type I and II diabetes, from age 28 to 35. The mean duration of disease was 9 years. Patients were divided in two groups. In group I were included 15 patients which got α-lipoic acid in order to prevent peripheral diabetic neuropathy in dos...